Page last updated: 2024-10-28

guaifenesin and Sarcoidosis, Pulmonary

guaifenesin has been researched along with Sarcoidosis, Pulmonary in 1 studies

Guaifenesin: An expectorant that also has some muscle relaxing action. It is used in many cough preparations.

Sarcoidosis, Pulmonary: Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reichenberger, F1
Kleiber, B1
Baschiera, B1
Bubendorf, L1
Brutsche, M1
Dalquen, P1
Tamm, M1

Other Studies

1 other study available for guaifenesin and Sarcoidosis, Pulmonary

ArticleYear
Bronchoalveolar lavage quality influences the T4/T8 ratio in sarcoidosis.
    Respiratory medicine, 2007, Volume: 101, Issue:9

    Topics: Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; CD4-CD8 Ratio; Cell Count; Cilia; Female; Huma

2007